Botfet / Company detail

AUPH

universe

Aurinia Pharmaceuticals Inc.

biotech

Moat score54out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic15.5%

Gross Margin88.5%

Revenue Cagr57.8%

Fcf Conversion47.1%

Fcf Yield6.0%

Interest Coverage29.5x

Market Cap B$2.3B

Pe7.1

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant54

Why it may endure

Moat breakdown

Quant: 54 · Curator: 0

Market Share Stability6

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener